Barnwell Industries (BRN) Stock Forecast, Price & News

Barnwell Industries' stock was trading at $2.9564 at the start of the year. Since then, BRN shares have decreased by 5.6% and is now trading at $2.79.
View the best growth stocks for 2023 here.

Barnwell Industries saw a drop in short interest during the month of May. As of May 15th, there was short interest totaling 3,500 shares, a drop of 64.6% from the April 30th total of 9,900 shares. Based on an average trading volume of 55,700 shares, the short-interest ratio is presently 0.1 days. Currently, 0.1% of the company's stock are short sold.
View Barnwell Industries' Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Thursday, August 10th 2023.
View our BRN earnings forecast.

Barnwell Industries, Inc. (NYSEAMERICAN:BRN) posted its quarterly earnings data on Tuesday, August, 11th. The energy company reported ($0.42) earnings per share for the quarter. The energy company had revenue of $3.98 million for the quarter. Barnwell Industries had a net margin of 29.07% and a trailing twelve-month return on equity of 53.58%.

Barnwell Industries announced a quarterly dividend on Tuesday, May 16th. Shareholders of record on Thursday, May 25th will be given a dividend of $0.015 per share on Monday, June 12th. This represents a $0.06 dividend on an annualized basis and a dividend yield of 2.15%. The ex-dividend date of this dividend is Wednesday, May 24th.
Read our dividend analysis for BRN.

Barnwell Industries (NYSEAMERICAN:BRN) pays an annual dividend of $0.06 per share and currently has a dividend yield of 2.15%. The dividend payout ratio is 8.22%. This payout ratio is at a healthy, sustainable level, below 75%.
Read our dividend analysis for BRN.

Based on aggregate information from My MarketBeat watchlists, some companies that other Barnwell Industries investors own include Ampio Pharmaceuticals (AMPE), Gold Resource (GORO), Navidea Biopharmaceuticals (NAVB), Pfizer (PFE), Abeona Therapeutics (ABEO), Arbutus Biopharma (ABUS), Aerie Pharmaceuticals (AERI), Applied Genetic Technologies (AGTC) and Akers Biosciences (AKER).

Barnwell Industries trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "BRN."

Barnwell Industries' stock is owned by many different institutional and retail investors. Top institutional shareholders include Renaissance Technologies LLC (3.86%), Stilwell Value LLC (1.00%), BlackRock Inc. (0.68%), Dimensional Fund Advisors LP (0.58%), Susquehanna International Group LLP (0.34%) and Apexium Financial LP (0.12%). Insiders that own company stock include Alexander C Kinzler, Colin R O'farrell, Douglas N Woodrum, Joseph Eugene Magaro, Joshua Horowitz, Kenneth S Grossman, Ned L Sherwood, Peter J O'malley and Russell M Gifford.
View institutional ownership trends.

Shares of BRN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of BRN stock can currently be purchased for approximately $2.79.

Barnwell Industries (NYSEAMERICAN:BRN) has a market capitalization of $27.78 million and generates $18.11 million in revenue each year. The energy company earns $6.25 million in net income (profit) each year or $0.73 on an earnings per share basis.

Barnwell Industries' mailing address is 1100 Alakea St Ste 2900, HONOLULU, HI 96813, United States. The official website for the company is www.brninc.com. The energy company can be reached via phone at (808) 531-8400, via email at barnwellinfo@brninc.com, or via fax at 808-531-7181.